Please provide your email address to receive an email when new articles are posted on . In this video, Healio spoke with Farhad Ravandi, MD, about the promise of maintenance therapy in AML, which was ...
Please provide your email address to receive an email when new articles are posted on . In this video Aaron T. Gerds, MD, assistant professor in medicine at the Cleveland Clinic Taussig Cancer ...
Acute myeloid leukemia (AML) is an aggressive form of blood cancer that causes the uncontrolled growth of abnormal myeloid cells. It predominantly affects the bone marrow and blood, but cancer cells ...
An all-oral regimen is a meaningful advance in newly diagnosed AML, yet early monitoring needs, complex dosing, and patient readiness lead many clinicians to begin cycle 1 intravenously.
Acute myeloid leukemia (AML) is a progressive type of cancer that affects your bone marrow and blood cells. Early detection and treatment are important to help increase the chances of survival from ...
At the European Hematology Association (EHA) 2025 Congress, Ashley Yocum, PhD, highlights how the Beat AML Master Trial advances safe, personalized treatment and expands targeted therapy options for ...
Acute myeloid leukemia (AML) is a type of cancer that begins in the blood-forming cells of the bone marrow. Doctors do not stage AML like many other cancers, as it does not typically form tumors.